Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma. (2019)
Attributed to:
Integrating innovative technologies for genotyping and phenotyping in stratified medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.27156
PubMed Identifier: 31497252
Publication URI: http://europepmc.org/abstract/MED/31497252
Type: Journal Article/Review
Volume: 10
Parent Publication: Oncotarget
Issue: 50
ISSN: 1949-2553